More Articles Back to Article
Moderna's COVID-19 vaccine under rolling review in EU
The European Medicines Agency's Committee for Medicinal Products for Human Use has initiated a rolling review for Moderna's mRNA-1273 vaccine candidate and is assessing the first set of data submitted. Moderna had said in October it would file for real-time review of its COVID-19 vaccine in Europe and announced this month that it had sufficient data for a first interim analysis of the company's Phase III COVID-19 vaccine trial. Reuters (11/16)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!